Blood pressure control

Blood pressure control has been studied in 49 papers since 2016: 4 trials and 15 observational studies in people, 30 reviews; 18 in the past year. The newest story, Oct 26, 2026: “Lower pressure tied to fewer strokes after angioplasty at 80 and up”.

InterventionHuman trials

49 papers study it42 findingsUpdated

4 new papers in 30 daysSee all 49 papers on blood pressure control

At a glance

Blood pressure control is linked with longer life expectancy and more cardiometabolic disease-free years in adults with hypertension; independent labs also report links with lower mortality and cognitive impairment. A human trial reports less cognitive impairment with intensive control. A preprint reports no clear cardiovascular mortality link among participants with comorbidity.

42 findings in 30 papers from 2016 to 2026, 7 of them since May 2026

Independent labs found the same change in people. 13 independent labs in 5 countries; 2 trials, none about aging, 1 with no results posted.

“Reductions in LD-PWV under intensive BP control were associated with 21% risk reduction for cognitive impairment.”
Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT)Alzheimer's & dementia : the journal of the Alzheimer's Association2026doi:10.1002/alz.71444

1 of its findings points the other way.

Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
  • 13 independent labs in 5 countries
  • 1 finding against
  • 2 trials, none about aging, 1 with no results posted
  • Funders: National Heart, Lung, and Blood Institute and others
  • Human trial4
  • Humans15

Studies in people

1 study gave blood pressure control to people and measured what changed.

What changedDesignPeopleSource

down: Lowers the risk of cognitive impairment21% risk reduction

Randomized trial3 years614 peopleOlder adults; under intensive BP controlAlzheimer's & dementia : the journal of the Alzheimer's Association, May 1, 2026

What did studies of blood pressure control find?

17

Studies of blood pressure control measured 17 outcomes, among them cognitive decline, neuropsychological test performance and cognitive impairment.

Cognitive decline

downin humans2

2 studies
  1. Blood pressure control decreases cognitive decline in patients with comorbid hypertension and cognitive impairment.

    “Achieving specific BP goals can improve clinical outcomes and possibly slow down cognitive decline for patients with comorbid hypertension and cognitive impairment.”

    Reviewin patients with comorbid hypertension and cognitive impairment

    Hypertension and Cognitive Disorders

    Cardiology in review

  2. Blood pressure control decreases cognitive decline in humans.

    “blood pressure control in middle-aged subjects may delay or stop the progression of cognitive decline”

    Review

    Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?

    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

Neuropsychological test performance

no changein humans1

1 study
  1. Blood pressure control showed no clear effect on neuropsychological test performance in humans (Controlled versus uncontrolled hypertension).

    “the individual neuropsychological tests analyzed (verbal fluency, delayed word recall, digit symbol substitution, and digit span) did not reveal significant differences between these groups.”

    ReviewControlled versus uncontrolled hypertension

    Cognitive impairment in uncontrolled vs controlled hypertension – systematic review and meta-analysis

    European journal of internal medicine

Cognitive impairment

downin humans1

1 study
  1. Blood pressure control protects against cognitive impairment in humans.

    “identifies blood pressure control as the best-established intervention”

    Review

    Cognition in Cardiovascular Disease

    Current neurology and neuroscience reports

More on Cognitive impairment

Cardiometabolic disease-free life expectancy

upin humans1

1 study
  1. Blood pressure control is linked with higher cardiometabolic disease-free life expectancy in humans (high vs low SBP-TTR in adults with hypertension) (6.18 additional CMD-free years).

    “high SBP-TTR was associated with 1.51 additional years of total life expectancy and 6.18 additional CMD-free years, alongside a 4.67-year reduction in CMD-lived life expectancy”

    Humanshigh vs low SBP-TTR in adults with hypertensionmean follow-up of 11.94 yearsn = 18,503

    Time in target systolic blood pressure range and cardiometabolic disease-free life expectancy in hypertensive elderly

    American journal of preventive cardiology

Life expectancy

upin humans1

1 study
  1. Blood pressure control is linked with higher life expectancy in humans (high vs low SBP-TTR in adults with hypertension) (1.51 additional years).

    “Compared with low SBP-TTR, high SBP-TTR was associated with 1.51 additional years of total life expectancy and 6.18 additional CMD-free years, alongside a 4.67-year reduction in CMD-lived life expectancy.”

    Humanshigh vs low SBP-TTR in adults with hypertensionmean follow-up of 11.94 yearsn = 18,503

    Time in target systolic blood pressure range and cardiometabolic disease-free life expectancy in hypertensive elderly

    American journal of preventive cardiology

Functional outcomes

upin humans1

1 study
  1. Blood pressure control improves functional outcomes in patients with mild to moderate ICH (SBP to 130-150 mm Hg).

    “early lowering of SBP to 130-150 mm Hg with smooth, sustained BP control is safe and may improve functional outcomes in patients with mild to moderate ICH”

    Reviewin patients with mild to moderate ICH

    Current Management of Resistant Hypertension in Patients with Intracerebral Hemorrhage

    International journal of molecular sciences

Mortality

downin humans1HR 0.55

1 study
  1. Blood pressure control decreases mortality in patients receiving multifactorial intensive therapy (HR = 0.55, P = 0.041).

    “blood pressure control (HR = 0.55, P = 0.041) were significant predictors in the MT group”

    Human trialin patients receiving multifactorial intensive therapyn = 184

    Impact of achieving glycated hemoglobin targets on cardiovascular events/mortality: Post-hoc analysis of the nephropathy in diabetes type 2 trial

    World journal of diabetes

Hypertension-related adverse outcomes

upin humans1

1 study
  1. Blood pressure control improves hypertension-related adverse outcomes in older adults.

    “several randomized clinical trials (RCTs) evaluating antihypertension strategies in older adults have concluded that the potential benefits of intensive BP management outweigh the risks of harm.”

    Reviewin older adults

    Review of Blood Pressure Control in Vulnerable Older Adults: The Role of Frailty and Sarcopenia

    Journal of vascular diseases

Cardiovascular disease

downin humans1

1 study
  1. Blood pressure control decreases cardiovascular disease in humans.

    “Intensive control reduces cardiovascular events, as seen in the SPRINT, PROGRESS and STEP studies”

    Review

    Blood pressure management to prevent recurrent stroke: current evidence and perspectives

    NPJ cardiovascular health

More on Cardiovascular disease

Cardiovascular disease mortality

no changein humans1

1 study
  1. Blood pressure control was not clearly linked with cardiovascular disease mortality in participants with comorbidity (P >0.05).

    “ideal BP levels were not significantly associated with CVD mortality in participants with comorbidity ( P >0.05).”

    Humansin participants with comorbidityn = 1,905

    Impact of blood pressure control level on all-cause mortality and CVD mortality in patients with hypertension and its comorbidities: A prospective cohort study in Southwest China

    medRxivPreprint

NfL

upin humans1

1 study
  1. Blood pressure control increases NfL in humans (intensive versus standard blood pressure control).

    “Intensive treatment was associated with larger increases in NfL compared to standard treatment.”

    Human trialintensive versus standard blood pressure controlplasmaBP target < 120 mm Hg versus < 140 mm Hg3.8 yearsn = 517

    Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on NfL

Plasma amyloid beta and total tau

no changein humans1

1 study
  1. Blood pressure control showed no clear effect on plasma amyloid beta and total tau in humans (intensive versus standard blood pressure control).

    “Over 3.8 years, there were no significant between-group differences for Aβ40, Aβ42, Aβ42 /Aβ40, or total tau.”

    Human trialintensive versus standard blood pressure controlplasmaBP target < 120 mm Hg versus < 140 mm Hg3.8 yearsn = 517

    Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)

    Alzheimer's & dementia : the journal of the Alzheimer's Association

More on Plasma amyloid beta and total tau

All 17

What is blood pressure control linked with?

17

Studies link blood pressure control with 17 measures, among them cognitive impairment, cardiovascular disease and mild cognitive impairment.

Cognitive impairment

downin humans3−21% risk reductionOR 0.32

3 studies
  1. Blood pressure control lowers the risk of cognitive impairment in humans under intensive BP control (21% risk reduction).

    “Reductions in LD-PWV under intensive BP control were associated with 21% risk reduction for cognitive impairment.”

    Human trialunder intensive BP control3 yearsn = 614

    Changes in arterial stiffness under blood pressure control are independently associated with cognitive impairment: The Systolic Blood Pressure Intervention Trial (SPRINT)

    Alzheimer's & dementia : the journal of the Alzheimer's Association

  2. Blood pressure control is linked with a lower risk of cognitive impairment in humans (hypertension).

    “Blood pressure control in the hypertensive group was significantly associated with a lower risk of cognitive impairment.”

    Humanshypertensionn = 5,860

    Correlation between blood pressure control status and cognitive impairment in older adults: A national cross-sectional study

    PloS one

  3. Blood pressure control is associated with cognitive impairment in humans (Controlled versus uncontrolled hypertension; significant only among adults ≥65 years) (OR 0.32, 95% CI: 0.13, 0.80).

    “The prevalence of CImp was lower in the group with well-controlled hypertension (OR 0.32, 95% CI: 0.13, 0.80)”

    ReviewControlled versus uncontrolled hypertension; significant only among adults ≥65 years

    Cognitive impairment in uncontrolled vs controlled hypertension – systematic review and meta-analysis

    European journal of internal medicine

More on Cognitive impairment

Cardiovascular disease

downin humans3

3 studies
  1. Blood pressure control lowers the risk of cardiovascular disease in humans.

    “elucidated the benefits of blood pressure control in older adults”

    Review

    Management of Hypertension in Older Adults

    Korean Journal of Geriatrics & Gerontology

  2. Blood pressure control lowers the risk of cardiovascular disease in hypertensive patients with and without diabetes.

    “pharmacological blood pressure (BP) lowering and lifestyle interventions (e.g., sodium restriction, exercise) generally reduce risk”

    Reviewin hypertensive patients with and without diabetes

    Impact of Blood Pressure Control on Stroke and Myocardial Infarction Risk in Hypertensive Patients With and Without Diabetes: A Narrative Review

    Cureus

  3. Blood pressure control lowers the risk of cardiovascular disease in patients with chronic kidney disease and hypertension.

    “blood pressure control is crucial in reducing the human and socio-economic burden of renal and cardiovascular outcomes in those patients”

    Reviewin patients with chronic kidney disease and hypertension

    Tight Blood Pressure Control in Chronic Kidney Disease

    Journal of cardiovascular development and disease

More on Cardiovascular disease

Mild cognitive impairment

downin humans2OR 0.44

2 studies
  1. Blood pressure control is linked with a lower risk of mild cognitive impairment in patients with hypertension (OR 0.44, 95% CI 0.30-0.65).

    “controlling blood pressure to "normal" target values helped decrease the incidence of MCI (OR=0.44, 95% CI 0.30-0.65)”

    Humansin patients with hypertension

    The Association Between the Duration, Treatment, Control of Hypertension and Lifestyle Risk Factors in Middle-Aged and Elderly Patients with Mild Cognitive Impairment: A Case-Control Study

    Neuropsychiatric disease and treatment

  2. Blood pressure control lowers the risk of mild cognitive impairment in humans.

    “intensive blood pressure control may reduce the risk of mild cognitive impairment”

    Review

    The role of treatment of arterial hypertension, inflammatory and metabolic disorders in the struggle for active longevity

    Eurasian heart journal

More on Mild cognitive impairment

Mortality

downin humans2HR 0.265

2 studies
  1. Blood pressure control is linked with a lower risk of mortality in hypertension patients compared with SBP>=140 mmHg and DBP>=90 mmHg (HR=0.265, 95%CI:0.111,0.630).

    “participants with SBP <120 mmHg and DBP <80 mmHg, they had the lowest risk of all-cause mortality (HR=0.265, 95%CI:0.111,0.630)”

    Humansin hypertension patients compared with SBP>=140 mmHg and DBP>=90 mmHg11.72 years median follow-upn = 1,905

    Impact of blood pressure control level on all-cause mortality and CVD mortality in patients with hypertension and its comorbidities: A prospective cohort study in Southwest China

    medRxivPreprint

  2. Blood pressure control lowers the risk of mortality in humans (hypertension) (< 140/90 mm Hg).

    “Evidence strongly supports reducing blood pressure to less than 140/90 mm Hg to reduce the risk of all-cause and cardiovascular mortality in adults with hypertension.”

    Reviewhypertension

    Hypertension in Adults: Initial Evaluation and Management

    American family physician

Dementia

downin humans2

2 studies
  1. Blood pressure control lowers the risk of dementia in humans (low-risk patients with stage I hypertension).

    “Blood pressure control in low-risk patients with stage I hypertension reduces the risk of dementia development, including Alzheimers disease.”

    Reviewlow-risk patients with stage I hypertension

    Cognitive impairment and the threat of dementia pandemic or the journey of hypertensive patients to self-care deficit

    Vnitrni lekarstvi

  2. Blood pressure control lowers the risk of dementia in humans.

    “blood pressure control in middle-aged subjects may delay or stop the progression of cognitive decline and reduce the risk of dementia in the elderly.”

    Review

    Can the Treatment of Hypertension in the Middle-Aged Prevent Dementia in the Elderly?

    High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension

More on Dementia

White matter hyperintensities

downin humans1

1 study
  1. Blood pressure control is associated with white matter hyperintensities in humans (Controlled versus uncontrolled hypertension) (SMD: 0.58, 95% CI: 0.08, 1.08).

    “white matter hyperintensities (WMH) tended to be less advanced among patients with controlled hypertension (SMD: 0.58, 95% CI: 0.08, 1.08).”

    ReviewControlled versus uncontrolled hypertensionbrain

    Cognitive impairment in uncontrolled vs controlled hypertension – systematic review and meta-analysis

    European journal of internal medicine

Stroke risk

downin humans1HR 0.34

1 study
  1. Blood pressure control is associated with stroke risk in humans After catheter revascularization; discharge BP <130/80 versus ≥130/80 mmHg (HR 0.34, 95% CI 0.17 to 0.68; 3-year absolute risk reduction 3.01% (95% CI 0.85% to 5.44%); NNT 33.3).

    “among patients aged ≥80 years, BP <130/80 mmHg was associated with a substantially lower risk of stroke”

    HumansAfter catheter revascularization; discharge BP <130/80 versus ≥130/80 mmHgMedian follow-up of 2.6 yearsn = 1,731

    Lower pressure tied to fewer strokes after angioplasty at 80 and up

    ESC Congress 2026 abstract

More on Stroke risk

Cardiometabolic disease-free life expectancy

upin humans1

1 study
  1. Blood pressure control is associated with cardiometabolic disease-free life expectancy in humans (progressive increase across SBP-TTR categories) (from 38.77 years (95% CI: 38.50-39.05) to 40.29 years (95% CI: 40.19-40.23)).

    “Estimated CMD-free life expectancy increased progressively across SBP-TTR categories, from 38.77 years (95% CI: 38.50-39.05) in the low group to 40.29 years (95% CI: 40.19-40.23) in the high group.”

    Humansprogressive increase across SBP-TTR categories

    Time in target systolic blood pressure range and cardiometabolic disease-free life expectancy in hypertensive elderly

    American journal of preventive cardiology

Diabetic kidney disease

downin humans1

1 study
  1. Blood pressure control lowers the risk of diabetic kidney disease in patients with diabetes.

    “earlier and more intensive blood pressure control to reduce cardiovascular events, stroke, heart failure, and progression of diabetic nephropathy”

    Reviewin patients with diabetes

    The 2025 AHA/ACC hypertension guidelines: implications for cardiovascular and renal risk in patients with diabetes

    Cardiovascular diabetology. Endocrinology reports

More on Diabetic kidney disease

Cardiovascular events

downin humans1

1 study
  1. Blood pressure control lowers the risk of cardiovascular events in patients with diabetes.

    “emphasizing earlier and more intensive blood pressure control to reduce cardiovascular events, stroke, heart failure, and progression of diabetic nephropathy”

    Reviewin patients with diabetes

    The 2025 AHA/ACC hypertension guidelines: implications for cardiovascular and renal risk in patients with diabetes

    Cardiovascular diabetology. Endocrinology reports

All 17

Has blood pressure control been tested in people?

0 of 2 about aging

Yes: 4 trials and 15 observational studies in people have been published, and 2 trials are registered.

In trials

Trial sponsors

Funding

18 grants since 2017

National Heart, Lung, and Blood Institute$16.1MJapan Society for the Promotion of Science¥7.4MNational Institute on Aging$602K

Contains public sector information licensed under the Open Government Licence v3.0.

How this record changed

  1. Summary written from the findings.

Latest

Dec 2025: 1Jan 2026: 1Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 1Jun 2026: 3Jul 2026: 2Aug 2026: 1Sep 2026: 2Oct 2026: 3Nov 2026: 218 papers in 12 months
ESC Congress 2026 Abstract

Lower pressure tied to fewer strokes after angioplasty at 80 and up

After angioplasty, blood pressure below 130/80 millimeters of mercury was linked to 3.01 percentage points lower three-year stroke risk than higher readings in patients…After angioplasty, blood pressure below 130/80 millimeters of mercury was linked to 3.01 percentage points lower three-year stroke risk than higher readings in patients 80 and older.

Cohort · 1,731 peoplePopulations

See all 49 papers on blood pressure control